SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-140921
Filing Date
2021-11-18
Accepted
2021-11-18 08:30:30
Documents
14
Period of Report
2021-11-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133287d1_8k.htm   iXBRL 8-K 26978
2 EXHIBIT 99.1 tm2133287d1_ex99-1.htm EX-99.1 92519
3 GRAPHIC tm2133287d1_ex99-1img001.jpg GRAPHIC 3964
  Complete submission text file 0001104659-21-140921.txt   308776

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20211118.xsd EX-101.SCH 3016
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20211118_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgtx-20211118_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2133287d1_8k_htm.xml XML 3599
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40886 | Film No.: 211422677
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences